Table 1.
Descriptive characteristics of participants at baseline by group
| Rehabilitation group | Individual group | |
|---|---|---|
| N | 70 | 73 |
| Male/Female | 41/29 (59/41) | 44/29 (60/40) |
| Age, years | 58.5 ± 9.0 | 58.0 ± 10.3 |
| Diabetes duration, years (range) |
6.7 (0-37) | 6.4 (0-24) |
| - Newly diagnosed diabetes | 14 (20) | 12 (15) |
| HbA1c, % | 7.9 ± 0.8 | 7.8 ± 0.9 |
| Weight, kg | 96.2 ± 15.2 | 98.2 ± 24.8 |
| Smokers/Ex-smokers | 15/27 (21/39) | 13/36 (18/49) |
| No antidiabetic drugs | 9 (13) | 17 (23) |
| OAD only | 48 (68) | 46 (63) |
| Insulin | 13 (19) | 10 (14) |
| Microalbuminuria | 9 (13) | 14 (19) |
| Macroalbuminuria | 3 (4) | 3 (4) |
| Retinopathy | 4 (6) | 3 (4) |
| Peripheral neuropathy | 28 (40) | 24 (33) |
| Cardiovascular event | 8 (11) | 9 (12) |
Mean ± SD or N (%). OAD: Oral Antidiabetic Drug. Microalbuminuria was defined as a urine Albumin:Creatinine Ratio (ACR) ≥ 2.5 - 25 mg/mmol in men and ≥ 3.5 - 25 mg/mmol in women. Macroalbuminuria: ARC > 25 mg/mmol. Peripheral neuropathy was defined as biothesiometric value > 25 volt. Cardiovascular event: Myocardial infarction, Coronary revascularization, Angina pectoris or Stroke.